Dr. Martin is a 30-year veteran of the drug testing industry and brings a wide variety of national and international experience to the DATIA Board of Directors.
Washington, DC (PRWEB) June 10, 2010
At DATIA’s annual meeting in Phoenix June 2-4, 2010 DATIA announced the appointment of its new Chairman of the Board of Directors; Dave Martin, PhD, President of JMJ Technologies in Lansdale, PA. Laura Shelton, DATIA’s Executive Director stated, “Dr. Martin is a 30-year veteran of the drug testing industry and brings a wide variety of national and international experience to the DATIA Board of Directors.” Dr. Martin remarked, “I am grateful for this opportunity and see DATIA expanding into areas outside of the workplace as drug testing becomes more common in our society. It is simply a matter of good business sense - as drug abuse costs our nation over a billion dollars a year in lost productivity, accidents and theft. It is a also a public safety and national security issue as drug profits fuel domestic and international violent crimes, including terrorism.”
About DATIA: The Drug and Alcohol Testing Industry Association (DATIA) was founded in 1995 and has grown to be the largest and most influential association for the industry. DATIA represents the entire spectrum of drug and alcohol testing providers including: collection sites, laboratories, consortiums, third party administrators, medical review officers, employers, substance abuse professionals, and equipment manufacturers. DATIA’s goals are to represent the drug and alcohol testing industry in Washington, DC on key legislative and regulatory issues, to expand drug and alcohol testing, to provide members with vital industry information, resources and benefits important to their operations, and to promote the highest possible standards for the industry. To contact DATIA call Laura Shelton at 800-355-1257 ext. 40, write to 1325 G Street NW Suite 500 #5001 Washington, DC 20005, or email lshelton(at)datia(dot)org.